The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.
NYS Entity Status
NYS Filing Date
OCTOBER 31, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - LA BAMBA BAR LOUNGE INC.
AROUND THE WEB
- Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
By LIAM STACK - Monday Jun 19, 2017
- The Agony Of Receipt ...
Tuesday Oct 15, 2013
I have a new car, and I took my baby in for its first oil change and "once-over" at the dealership that's close to my office. It's not where I bought the car but it is convenient to me for servicing,with a fab wifi lounge and coffee bar so I can get some work done while my hot tamale gets a checkup.
- Walmart to Buy Bonobos, Men’s Wear Company, for $310 Million
By MICHAEL J. de la MERCED - Friday Jun 16, 2017
Acquiring the clothing brand born on the internet is intended to energize Walmart’s e-commerce strategy as it races to catch up with Amazon.
- Stonewall Inn Project to Preserve Stories Behind a Gay Rights Monument
By SARAH MASLIN NIR - Saturday Jun 17, 2017
A $1 million grant will go toward conserving the oral histories of those who lived through the 1969 riots.
- Five Sites of New York’s L.G.B.T. History
Monday Jun 19, 2017
Jacob Riis Park, a Manhattan church, the Bum Bum Bar and more. In 360 degrees, visit five sites that helped shape New York City’s L.G.B.T. community and its history.
- Amazon to Buy Whole Foods in $13.4 Billion Deal
By MICHAEL J. de la MERCED and NICK WINGFIELD - Friday Jun 16, 2017
The deal is the online giant’s latest push into food retailing.
- Road Trip: Karaoke Coast to Coast
By MARIAN BULL - Tuesday Jun 13, 2017
In Richmond, Nashville and beyond, taking the mike reveals a sense of place, and the catharsis of belting out “Jesse’s Girl.”
- Insurers Battle Families Over Costly Drug for Fatal Disease
By KATIE THOMAS - Thursday Jun 22, 2017
The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.